Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
0.241
|
0.0178
|
0.0178
|
0.0178
|
0.0178
|
|
|
|
1.00
|
0.0115
|
0.024
|
0.015
|
0.015
|
0.015
|
0.015
|
|
|
|
1.00
|
0.005
|
0.04
|
0.022
|
0.0218
|
0.022
|
0.0218
|
|
|
26.20
|
4.00
|
0.01
|
0.0158
|
0.0198
|
0.0198
|
0.0198
|
0.0198
|
|
|
|
1.00
|
0.0115
|
0.029
|
0.0202
|
0.0202
|
0.0202
|
0.0202
|
|
|
|
1.00
|
0.0198
|
0.026
|
0.0201
|
0.0198
|
0.026
|
0.026
|
|
|
406.00
|
8.00
|
0.0115
|
0.0201
|
0.0209
|
0.0208
|
0.0209
|
0.0208
|
|
|
6.42
|
3.00
|
0.0196
|
0.04
|
0.0209
|
0.0209
|
0.0209
|
0.0209
|
|
|
|
1.00
|
0.02
|
0.055
|
0.0203
|
0.0203
|
0.026972
|
0.026972
|
|
|
8.12
|
3.00
|
0.02
|
0.193
|
0.0298
|
0.0201
|
0.0298
|
0.0202
|
|
|
79.17
|
4.00
|
TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.